Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organization (CRO) and drug discovery company, and Enamine Ltd (“Enamine”), the ...

Browse the complete list of chemical compound collections available at HTB, ranging from broad diversity libraries to focused sets tailored for specific pathways, targets, and disease areas. 12 New ...

Study Shows that NPs Aid in the Development of Scaffolds for Med-Chem Optimization There is a recurring trend in modern drug discovery that involves looking at natural products (NPs) as a source of ...

Until recently, the principal way to study changes in cellular protein expression levels and perform protein functional analysis was by fluorescent reporter proteins combined with automated confocal ...

This article and associated images are based on a poster originally authored by Steven D. Broadbent, Sian Humphrey, Signe Springe, Sung Min Yang, Ayan Ghoshal, Nina Dedic and Ashley Barnes and ...

Rui Wang of Wanhuida Intellectual Property says inventors should focus on improving AI systems’ transparency and predictability to enhance their patentability and identifies a challenge resulting from ...

Martin Clasby receives funding from the National Institutes of Health and Michigan Drug Discovery. Modern drug discovery is an expensive and complicated process. Hundreds of scientists and at least a ...

CAMBRIDGE, England & KYIV, Ukraine--(BUSINESS WIRE)--Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organisation (CRO) and drug ...